NM_002745.5:c.609+2319C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002745.5(MAPK1):c.609+2319C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.343 in 151,654 control chromosomes in the GnomAD database, including 9,553 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.34 ( 9553 hom., cov: 30)
Consequence
MAPK1
NM_002745.5 intron
NM_002745.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.76
Publications
17 publications found
Genes affected
MAPK1 (HGNC:6871): (mitogen-activated protein kinase 1) This gene encodes a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. The activation of this kinase requires its phosphorylation by upstream kinases. Upon activation, this kinase translocates to the nucleus of the stimulated cells, where it phosphorylates nuclear targets. One study also suggests that this protein acts as a transcriptional repressor independent of its kinase activity. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Two alternatively spliced transcript variants encoding the same protein, but differing in the UTRs, have been reported for this gene. [provided by RefSeq, Jan 2014]
MAPK1 Gene-Disease associations (from GenCC):
- Noonan syndrome 13Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.417 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAPK1 | ENST00000215832.11 | c.609+2319C>T | intron_variant | Intron 4 of 8 | 1 | NM_002745.5 | ENSP00000215832.7 | |||
MAPK1 | ENST00000398822.7 | c.609+2319C>T | intron_variant | Intron 4 of 7 | 1 | ENSP00000381803.3 | ||||
MAPK1 | ENST00000544786.1 | c.609+2319C>T | intron_variant | Intron 4 of 6 | 1 | ENSP00000440842.1 |
Frequencies
GnomAD3 genomes AF: 0.343 AC: 51939AN: 151536Hom.: 9561 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
51939
AN:
151536
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.343 AC: 51951AN: 151654Hom.: 9553 Cov.: 30 AF XY: 0.337 AC XY: 24992AN XY: 74140 show subpopulations
GnomAD4 genome
AF:
AC:
51951
AN:
151654
Hom.:
Cov.:
30
AF XY:
AC XY:
24992
AN XY:
74140
show subpopulations
African (AFR)
AF:
AC:
9049
AN:
41292
American (AMR)
AF:
AC:
5588
AN:
15236
Ashkenazi Jewish (ASJ)
AF:
AC:
1677
AN:
3462
East Asian (EAS)
AF:
AC:
1074
AN:
5144
South Asian (SAS)
AF:
AC:
1564
AN:
4798
European-Finnish (FIN)
AF:
AC:
3076
AN:
10536
Middle Eastern (MID)
AF:
AC:
136
AN:
294
European-Non Finnish (NFE)
AF:
AC:
28549
AN:
67876
Other (OTH)
AF:
AC:
846
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1645
3290
4935
6580
8225
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
506
1012
1518
2024
2530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
884
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.